Kohjin Bio Co., Ltd. (TYO:177A)
Japan flag Japan · Delayed Price · Currency is JPY
580.00
-35.00 (-5.69%)
Nov 18, 2026, 11:23 AM JST

Kohjin Bio Income Statement

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
4,3824,9395,2064,7704,7423,947
Revenue Growth
-15.78%-5.13%9.14%0.59%20.14%25.81%
Cost of Revenue
2,9093,0822,8412,8892,2881,907
Gross Profit
1,4731,8572,3651,8812,4542,040
Selling, General & Admin
1,2021,2351,2061,0241,1861,069
Research & Development
250250168240--
Operating Expenses
1,4821,5151,3741,2841,1861,069
Operating Income
-93429915971,268971
Interest Expense
-40-38-30-22-32-38
Interest & Investment Income
442---
Earnings From Equity Investments
1833987110-29
Currency Exchange Gain (Loss)
-2-2-6-55
Other Non Operating Income (Expenses)
3023-1829
EBT Excluding Unusual Items
13411,0646341,243918
Gain (Loss) on Sale of Investments
-9-9----
Gain (Loss) on Sale of Assets
--1--1
Asset Writedown
--10----
Other Unusual Items
-110-51--3
Pretax Income
-93321,0146341,243922
Income Tax Expense
2081220250414335
Net Income to Company
-251794384829587
Net Income
-29251794384829587
Net Income to Common
-29251794384829587
Net Income Growth
--68.39%106.77%-53.68%41.23%-15.77%
Shares Outstanding (Basic)
555443
Shares Outstanding (Diluted)
555443
Shares Change
0.00%1.34%21.11%-22.96%-
EPS (Basic)
-5.6749.10157.4192.20199.04173.30
EPS (Diluted)
-5.6749.10157.4192.20199.04173.30
EPS Growth
--68.81%70.74%-53.68%14.85%-

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
176-27253261--
Free Cash Flow Per Share
34.43-53.2110.5162.66--
Dividend Per Share
10.00010.00024.00014.00019.000-
Dividend Growth
-58.33%-58.33%71.43%-26.32%--
Gross Margin
33.62%37.60%45.43%39.43%51.75%51.69%
Operating Margin
-0.21%6.92%19.04%12.52%26.74%24.60%
Profit Margin
-0.66%5.08%15.25%8.05%17.48%14.87%
Free Cash Flow Margin
4.02%-5.51%1.02%5.47%--
EBITDA
3747381,351896--
EBITDA Margin
8.54%14.94%25.95%18.78%--
D&A For EBITDA
383396360299--
EBIT
-93429915971,268971
EBIT Margin
-0.21%6.92%19.04%12.52%26.74%24.60%
Effective Tax Rate
-24.40%21.70%39.43%33.31%36.33%